Hemicholinium-3, troxypyrollium • Weak bases and protonophores that disrupt Ammonia, nigericin the proton gradient • Activity (Searl et al., 1990) Increase Quantal Size
• Overexpression of VAChT (Song et al., 1997) • Epinephrine and cAMP derivatives
Blocked by vesamicol and PKA inhibitors Frog NMJ, but not mouse
• Insulin
Blocked by vesamicol, but not PKA inhibitors Frog NMJ, but not mouse • Prolonged hypertonic solution
Blocked by vesamicol and PKA inhibitors • Activity (Lupa, 1988) **(Van der Kloot, 1991; Parsons et al., 1993; Van der Kloot and Molgo, 1994) .
The metabolic transport activity in both VP1 and VP2 Additional evidence for this interpretation is the finding that production of the smaller quanta is inhibited by vesicles is blocked by vesamicol.
Vesamicol Predicts Functional Properties
vesamicol. The snake is unique in showing this stimulation-induced bimodality, so for further work in the rat, of the VAChT and Cholinergic Vesicles Unfortunately, technical problems prevent electrophysivesamicol had to be used to uncover the two populations. With stimulation in nonsaturating concentrations ology measurements in Torpedo, but functional measurements in other NMJ preparations show the same of vesamicol, there are two populations of quanta at the rat NMJ (Searl et al., 1991) . With saturating doses, distinction between preformed and recycling vesicles. These functional studies have utilized vesamicol inhibiuniform quantal size presumably results from complete masking of the recycling population. Quantal size was tion of the VAChT to unmask the recycling population of vesicles.
not measured after prolonged stimulation in the presence of vesamicol, but the average response to nerve Vesamicol has no effect in unstimulated preparations, but prolonged nerve stimulation in the presence of vesastimulation was shown to decrease more than controls. After stimulation in the presence of nonsaturating doses micol leads to a uniform decrease in quantal size (reviewed by Prior and Tian, 1995) . At the NMJ, a change of vesamicol, it would be interesting to see if the quantal size recovers with rest. in quantal size can result from either a change in the amount of ACh in a vesicle or a change in the sensitivity Another line of evidence for multiple populations of cholinergic vesicles is found with the cat superior cerviof the postsynaptic receptors. In the presence of moderate doses of vesamicol, no postsynaptic changes were cal ganglion (Cabeza and Collier, 1988) . These experiments did not measure quanta but instead studied the found with application of the cholinergic agonist carbachol, so the decreased quantal size is most likely from release of ACh using perfused ganglia. With nerve stimulation in the presence of vesamicol, release is inhiba change in the amount of transmitter (Parsons et al., 1993) . This result is consistent with populations of both ited after ‫%41ف‬ of initial tissue ACh is liberated. This gives an estimate of the size of the preformed populapreformed and recycling vesicles. Vesamicol has no effect on the preformed vesicles, but inhibits the filling of tion of cholinergic vesicles being ‫%41ف‬ of tissue ACh stores. Estimates of the size of preformed quanta have the recycling vesicles. Without vesamicol, prolonged 10 Hz nerve stimulation can continue unabated, and also been made in terms of numbers of vesicles. The estimates vary widely depending on the preparation: quantal size will actually be potentiated (Lupa, 1988) . However, in the presence of vesamicol, once the popula-‫000,07ف‬ at rat NMJ; ‫000,007ف‬ at frog NMJ; and ‫000,003ف‬ for snake NMJ (Prior and Tian, 1995) . When tion of preformed vesicles is released, the quantal size begins to decrease as incompletely filled, recycling vesi-HC-3 is used instead of vesamicol, ‫%58ف‬ of initial tissue ACh is released (Parsons et al., 1993) . This is much difcles are released.
A pair of papers by Searl et al. (1990 Searl et al. ( , 1991 provide ferent than the ‫%41ف‬ release found with vesamicol, but HC-3 is thought to inhibit release after depletion of both further evidence for multiple populations of cholinergic vesicles. In a snake NMJ preparation, prolonged nerve preformed vesicles and also cytoplasmic ACh stores. Molecular Mechanism of Vesicle Loading stimulation produces two populations of quanta (Searl et al., 1990) . One population is the same size as those
The VAChT belongs to a family with four classes of transporters that fill vesicles with neurotransmitter. The found before stimulation, but the second population is decreased in size in a stimulation frequency-dependent classes include those for glutamate, GABA-glycine, ACh, and monoamines. Mutants that are defective in manner. Histograms of the quantal size are well fit by two Gaussians, and the two populations are interpreted neuromuscular transmission led to the cloning of the first VAChT from C. elegans, and homologs from Toras the normal-sized population of preformed vesicles and a smaller-sized population of recycling vesicles.
pedo, rat, and humans soon followed (reviewed by Usdin et al., 1995) . ACh is transported in membranes from PC12 cells stably expressing the human VAChT clone (Varoqui and Erickson, 1996) . Sequence analysis of these transporters predicts a 12 transmembrane domain topology with potential sites for N-glycosylation and PKC phosphorylation. Conserved aspartate residues are found in putative transmembrane domains I, VI, X, and XI. The vesicular transporters are homologous to bacterial multidrug resistance transporters but not to the plasma membrane transport systems that remove neurotransmitters from the synaptic cleft. A ''cholinergic gene locus'' codes for the VAChT and choline acetyltransferase. The gene for the VAChT is contained within the first intron of choline acetyltransferase (references in Usdin et al., 1995) . This gene structure is conserved phylogenetically, and there is evidence for coordinated expression. The relationship between the two genes provides a convenient way for the neuron to control two important determinants of vesicular loading: cytoplasmic concentrations of ACh and vesicular transport activity.
The next step is functional characterization of the VAChT but cannot be interpreted in the same way as other vesicular transporters or synaptic proteins. Investhe vesamicol experiments described above. The detigators could potentially fashion synapses emphasizing crease in quantal size is seen in unstimulated synapses, whatever particular properties they are interested in but vesamicol is added at the time of plating, so a popustudying. For example, it would be very interesting to lation of preformed vesicles may never form, or the preuse the same method when the vesicular glutamate formed vesicles may be already exhausted by the low transporter is cloned.
level, continuous spontaneous release. Nevertheless, Manipulation of the VAChT Changes Quantal Size the results show that different-sized populations of The most striking finding of the paper by Song et al. is quanta can be produced by modifying the activity of the that quantal size can be doubled in immature NMJs by VAChT. overexpression of the VAChT. Increased quantal size
In contrast to the results with overexpression of the can develop even the absence of a postsynaptic target;
VAChT, the quantal size and frequency can be demyocytes manipulated into contact with neurons record creased by mutation of conserved aspartate residues. increased quantal size with a time course that is probaMutation of the aspartate residue in transmembrane dobly too fast to be accounted for by a postsynaptic effect. main X of the VAChT leads to a significant decrease in Further evidence against a postsynaptic mechanism is quantal size and frequency. Surprisingly, mutation of that the rise and decay times of the response do not the conserved aspartate decreases quantal size and change when the amplitude is doubled, and that expresfrequency below the endogenous level. The authors sion of the VAChT in the postsynaptic muscle is without suggest that this may be due to oligomerization of the effect. The simplest interpretation of the increase in mutant protein with the endogenous Xenopus transportquantal size is that there is now more neurotransmitter ers or more likely from defects involving the proton grapackaged in vesicles.
dient. Overexpression of the VAChT also trebles the freHow Does a Vesicle Know It Is Full? quency of spontaneous release. This is more difficult to interpret than the increase in quantal size. One explanaModels of vesicle filling can be divided into two general categories: steady state models or set point models tion may be that more VAChTs cause maturation of the synapse or synaptic vesicles. Another explanation may (Figure 1 ). The vesicle can be filled based on the steady state between inflow and outflow, or the vesicle can fill be that increased loading of ACh uncovers quantal release by increasing the signal to noise ratio. Before overto a set point. At least at the immature NMJ, the results of Song et al. (1997) support a steady state model. expression of the VAChT, a population of small vesicles may be lost in the recording noise.
VP1 vesicles from Torpedo demonstrate active uptake of ACh, but the quantal size does not keep increasing. Song et al. use vesamicol to study the VAChT in their developing NMJ culture system. They show that vesamiThis implies that there is a leak mechanism that must be accounted for by the model. However, studies with col uniformly decreases the size and frequency of quantal release. The size of quanta in the presence of radiolabeled ACh and false transmitters suggest that the leak from preformed vesicles is relatively slow (Parvesamicol is reduced so much that part of the decrease in frequency may be explained by an inability to measure sons et al., 1993; Prior and Tian, 1995). The identity of the leak mechanism is unknown. quantal release that is lost in the recording noise. The A set point model would predict that with overexpresConclusion Expression of the VAChT may provide a way to regulate sion of the VAChT, vesicles would fill more quickly, but quantal size at the NMJ. By changing the area of postthat there would be no change in the amount of neurosynaptic membrane saturated with ACh (Bartol et al., transmitter in a filled vesicle. A set point could be created 1991), alteration in the amount of transmitter in a vesicle by a feedback mechanism, or if some component of the is an important determinant of quantal size. The coordiACh packaging mechanism is limiting. The activity of the nated expression of the VAChT and choline acetyltrans-V-type ATPases could create a set point, but previous ferase offers a convenient way for the neuron to control studies have demonstrated that proton-motive force is ACh metabolism, and the results of Song et al. show not the limiting factor in ACh loading (Parsons et al., that direct manipulations of VAChT expression can 1993). In addition, the results of Song et al. argue that change the quantal size in immature NMJs. Labeling vesicles cannot be filling to a set point in developing studies predict four VAChTs will be found on each vesiNMJs. If there were a set point, then vesicles would fill cle (Parsons et al., 1993) , but increases or decreases in faster with more transporters, but quantal size would this number could be used to modulate quantal size. not be doubled.
Furthermore, changes in the activity of the VAChT may A steady state model would predict that overexpresaccount for shorter-term regulation of quantal size. Apsion of the VAChT would lead to an increase in the plication of insulin leads to an increase in quantal size amount of neurotransmitter in the vesicle. Inflow can be that is not sensitive to protein synthesis inhibitors, but modeled as a function of the cytoplasmic concentration which is sensitive to vesamicol. Similarly, metabolic difof ACh, and a rate constant that includes the activity of ferences have been found between populations of chothe VAChT, proton pump, and any other components.
linergic vesicles from Torpedo; VP2 vesicles have a 4-to Assuming that the cytoplasmic concentration is rela-7-fold higher ratio of transport activity to vesamicol retively constant, then the inflow will be constant. The ceptor levels. outflow can be modeled as a function of the vesicular Mu-ming Poo and colleagues have found that immaACh concentration and a rate constant representing the ture NMJs have a skewed distribution of quantal sizes leak mechanism. The leak will increase as the concentradominated by small responses, but note that adult NMJ tion of ACh rises inside the vesicle. A bathtub analogy shows a Gaussian distribution of larger quantal sizes can be a helpful way to think about the steady state (Evers et al., 1989; Song et al., 1997) . Previous studies model. Let the faucet represent the inflow from the suggested that the skewed distribution in developing VAChT, and let the drain represent the leak mechanism.
synapses was largely the result of underdeveloped ACh If the faucet and drain are open, then a steady state packaging (Evers et al., 1989) . Although overexpression level will be reached in the tub where the inflow from of the VAChT in developing NMJ cultures does not by the faucet is balanced by the outflow from the drain.
itself lead to a Gaussian distribution of increased quantal However, if the flow from the faucet is turned up (i.e., sizes, mean quantal size is increased. Regulation of overexpression of the VAChT), then the bathtub will start
VAChT expression may be a way for the neuron to conto fill. As the fluid level rises, the outflow from the drain trol quantal size during the development of mature synwill also increase until it balances the inflow, but now aptic transmission. the steady state level will be higher than it was before Van der Kloot, W. (1991) . Prog. Neurobiol. 36, inhibited but the drain is still open. Possible explanations Van der Kloot, W., and Molgo, J. (1994) . Physiol. Rev. 74, include that the kinetics of the leak are relatively slow Varoqui, H., and Erickson, J.D. (1996) . J. Biol. Chem. 271, 27229- (Parsons et al., 1993; Prior and Tian, 1995) compared 27232. to experimental conditions, or that there is regulation of when vesicles can undergo steady state filling.
